• Metformin use may reduce risk for AMD

    2 monthes ago - By Healio

    Metformin use may be associated with a reduced risk for developing age-related macular degeneration, according to study results published in JAMA Ophthalmology.
    “Metformin, the most commonly prescribed oral antihyperglycemic drug for diabetes, has been shown to have anti-aging and protective effects against many age-associated diseases. In epidemiology studies, metformin lowers the risk of developing cardiovascular disease, stroke, cancer, dementia and primary open-angle glaucoma,” Andrea L. Blitzer, MD, University of Chicago Medical Center, and colleagues wrote. “Given the
    Read more ...

     

  • Visual, physical difficulties may increase in patients with late AMD

    2 monthes ago - By Healio

    Adults with late age-related macular degeneration may experience greater visual and physical difficulties compared with adults without AMD, according to study results published in Translational Vision Science and Technology.
    “AMD-related central vision loss is associated with difficulty with daily tasks such as reading and driving. As a larger proportion of the U.S. population is living well beyond the age of 60 years and are at risk of developing AMD, an understanding of the impact of AMD on visual and physical functioning in this population is of paramount importance,” William
    Read more ...